Takeda’s Shire takeover to bring $963 million fee bonanza
Banks, law firms and other advisers stand to earn up to $963 million in fees from Takeda Pharmaceutical’s $62 billion takeover of drugmaker Shire , according to documents for the deal published on Monday.